Project Grant HT94252310762
- Federal Project Grant Award Summary The University of Pennsylvania received a $812,487 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with an ultimate completion date of September 29, 2028. The award supports research titled "Modulating Liver Inflammation to Improve Outcomes in Pancreatic Cancer," to be conducted at the university's Philadelphia campus. Under this three-year...
- The Trustees of the University of Pennsylvania were awarded a $495,379 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program aims to transform health care for service members and the public...
- The Trustees of the University of Pennsylvania was awarded a $1,218,749 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 2021 through July 2024 to target retinoic acid signaling for immunotherapy in hepatocellular carcinoma. As part of the Military Medical Research and Development program's mission to transform military and public health through innovative medical research, this...
- The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
- This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
- The Trustees of the University of Pennsylvania were awarded a $560,870 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the...
- The University of Pennsylvania, through its Clinical Practices division, was awarded a $812,500 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting UGCG in the Melanoma Tumor Microenvironment." This 3-year research project, which commenced on September 1, 2024, aims to investigate innovative approaches to treating melanoma, a serious form of skin cancer, with a focus on modulating the tumor...
- Federal Grant Award Summary The University of Pennsylvania received a $1,305,270 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to establish the Ovarian Cancer Academy: Advancing Ovarian Cancer Research Through Mentorship, Networking, and Collaborations. The four-year award, which commenced on September 30, 2025 and extends through September 29, 2029, will be performed at the university's Philadelphia campus. This...
- The Trustees of the University of Pennsylvania were awarded a $1,624,578 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the mechanisms of mammary tumor recurrence from July 1, 2021 to June 30, 2024. Through this funding, the University of Pennsylvania will investigate medical solutions for breast cancer recurrence on the battlefield and for the American public...
- The Trustees of the University of Pennsylvania received a $296,595 Project Grant award from the Department of the Army Medical Command on September 15, 2022 to complete work by September 14, 2025. The grant supports the "Controlling the Burden of Metastatic Disease in Pancreatic Ductal Adenocarcinoma" project conducted in Philadelphia, PA under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through...
This Project Grant award of $1,625,000 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports in-vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer at the Trustees of the University of Pennsylvania. The research aims to advance scientific understanding and develop solutions for this important health challenge. The award commenced on September 1, 2023 and is scheduled for completion by August 31, 2027. As a private university and non-profit research institution, the University of Pennsylvania has extensive expertise in biomedical research, including numerous prior prime federal contract and grant awards across disciplines like infectious disease, neuroscience, and aerospace engineering. This grant expands their portfolio of work in the critical area of cancer research through innovative studies on the underlying mechanisms of liver cancer progression.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.6m | 8/29/23 |